Risk factors

FATE Therapeutics (FATE) risk factors

Item 1A of every FATE Therapeutics Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.

Open FATE in Gloom →
FATE Therapeutics' chart, financials and news, free in your browser.Open FATE in Gloom →
  • FY2025 10-K risk factors
    99 risks12 new8 dropped22 reworded

    Clinical trial delays and investigator inexperience with CAR-T therapies pose major hurdles for FATE's pipeline.

    Filed Feb 26, 2026
  • FY2024 10-K risk factors
    95 risks

    Accumulated deficit reached $1.4 billion as of December 31, 2024, with no approved products or commercial revenues.

    Filed Mar 05, 2025